velaglucerase alfa
HGT-GCB-087
Phase 3 mab completed
Quick answer
velaglucerase alfa for Gaucher Disease is a Phase 3 program (mab) at Shire with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shire
- Indication
- Gaucher Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed